Other

Dataset Information

0

Genome-wide CRISPR/Cas9 library screening identified OGDH as a regulator of disease progress and HMAs-resistance in MDS by reprogramming glutamine metabolism


ABSTRACT: Resistance of hypomethylating agents (HMAs) remains a challenge in myelodysplastic neoplasms (MDS), leading to a poor prognosis. Altered metabolism is also reported to be closely associated with drug resistance in hematological malignancies. Here, we conducted a genome-wide CRISPR/Cas9 library screening to identify candidate genes involved in drug sensitivity.

ORGANISM(S): Homo sapiens

PROVIDER: GSE273914 | GEO | 2024/08/05

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA1144074 | ENA
2024-07-25 | PXD050539 | Pride
2024-07-24 | GSE261338 | GEO
2024-07-24 | GSE261337 | GEO
2021-07-16 | E-MTAB-10635 | biostudies-arrayexpress
2022-05-02 | E-MTAB-11172 | biostudies-arrayexpress
2022-06-01 | GSE165064 | GEO
2021-02-08 | GSE151917 | GEO
2023-04-24 | GSE175758 | GEO
2022-08-31 | GSE171053 | GEO